CA Technologies
100 Baylis Rd, Ste 200, Melville, NY, 11747, US
Overview
CA together with its subsidiaries, engages in the design, development, marketing, licensing, and support of information technology (IT) management software products that operate on a range of hardware platforms and operating systems. The company has a portfolio of software products and services that address its customers needs for mainframe and distributed environments, spanning IT governance, IT management, and IT security. It focuses on various areas that include infrastructure management, project and portfolio management, security management, service management, application performance management, and data center automation and virtualization. CA offers Enterprise IT Management (EITM) software for organizations to manage IT in computing environments, which include people, information, processes, systems, networks, and applications, as well as databases from a Web service to the mainframe to a virtualized cloud, regardless of the hardware or software customers they are using. The company licenses its products principally to IT service providers, financial services companies, governmental agencies, retailers, manufacturers, educational institutions, and healthcare institutions worldwide through direct sales force, as well as indirectly through systems integrators, managed service providers, technology partners, EITM value-added resellers, original equipment manufacturers, and distribution and volume partners.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Cloud Computing
- Enterprise Software
- Information Technology
- Software
- Virtualization
Investment portfolio
- Watermark Medical
Led · Equity · Jun 2010
Watermark Medical makes an at-home headset called ARES that uses sensors to measure oxygen saturation, pulse, head movement and head position and combines that data with questionnaire responses to indicate sleep apnea risk. The company recently merged with sleep diagnostics provider SleepMed. According to the article, the ARES device has been tested in 100,000 patients since 2010. Watermark says its technology is intended to move sleep apnea testing out of expensive labs and into primary care. Insurer reimbursement changes have driven a broader industry push toward at-home testing, and the market for sleep-apnea diagnostics and treatments is becoming more competitive. Competitors mentioned include Cleveland Medical Devices, Itamar Medical and NovaSom. Watermark Medical develops a SaaS-based home sleep testing (HST) platform for the sleep-disordered breathing market. Its product, the Watermark ARES, enables medical practitioners to manage, aggregate and access critical diagnostic and historical patient information. The company sells and distributes the ARES through partners including PSS Medical, McKesson Corporation and Henry Schein. Watermark will use the new financing to further deploy its SaaS system across the sleep-disordered breathing market. The company is headquartered in Boca Raton, Florida. Watermark Medical develops medical products and services for diagnosing and managing sleep-disordered breathing. Its flagship product, the Watermark ARES (Apnea Risk Evaluation System), is an FDA-cleared wireless ambulatory sleep test device used to help diagnose obstructive sleep apnea. The company’s technology enables medical practitioners to access, manage, and aggregate critical diagnostic and historical patient information. The $15M equity investment from CA Technologies is intended to further develop that existing technology. CA and Watermark plan to collaborate to develop cloud-connected healthcare solutions. CA will take a minority stake in the company and hold two seats on Watermark’s board.